Literature DB >> 33494352

Natural and Synthetic Lactones Possessing Antitumor Activities.

Younghoon Kim1,2, Sandip Sengupta2, Taebo Sim1,2.   

Abstract

Cancer is one of the leading causes of death globally, accounting for an estimated 8 million deaths each year. As a result, there have been urgent unmet medical needs to discover novel oncology drugs. Natural and synthetic lactones have a broad spectrum of biological uses including anti-tumor, anti-helminthic, anti-microbial, and anti-inflammatory activities. Particularly, several natural and synthetic lactones have emerged as anti-cancer agents over the past decades. In this review, we address natural and synthetic lactones focusing on their anti-tumor activities and synthetic routes. Moreover, we aim to highlight our journey towards chemical modification and biological evaluation of a resorcylic acid lactone, L-783277 (4). We anticipate that utilization of the natural and synthetic lactones as novel scaffolds would benefit the process of oncology drug discovery campaigns based on natural products.

Entities:  

Keywords:  anticancer activities; drug discovery; natural lactones; natural product synthesis; synthetic lactones

Mesh:

Substances:

Year:  2021        PMID: 33494352      PMCID: PMC7865919          DOI: 10.3390/ijms22031052

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   6.208


  195 in total

Review 1.  Chemistry and biology of resorcylic acid lactones.

Authors:  Nicolas Winssinger; Sofia Barluenga
Journal:  Chem Commun (Camb)       Date:  2006-09-25       Impact factor: 6.222

2.  A radicicol-related macrocyclic nonaketide compound, antibiotic LL-Z1640-2, inhibits the JNK/p38 pathways in signal-specific manner.

Authors:  K Takehana; S Sato; T Kobayasi; T Maeda
Journal:  Biochem Biophys Res Commun       Date:  1999-04-02       Impact factor: 3.575

3.  A chiral pool approach for asymmetric syntheses of (-)-antrocin, (+)-asperolide C, and (-)-trans-ozic acid.

Authors:  Fu-Zhuo Li; Shuang Li; Peng-Peng Zhang; Zhi-Hui Huang; Wei-Bin Zhang; Jianxian Gong; Zhen Yang
Journal:  Chem Commun (Camb)       Date:  2016-10-13       Impact factor: 6.222

4.  Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides.

Authors:  Andreas Schirmer; Jonathan Kennedy; Sumati Murli; Ralph Reid; Daniel V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

5.  Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.

Authors:  Nicole Roberts; Bryan Kloos; Melanie Cassella; Simona Podgrabinska; Kris Persaud; Yan Wu; Bronislaw Pytowski; Mihaela Skobe
Journal:  Cancer Res       Date:  2006-03-01       Impact factor: 12.701

6.  Randomised double-blind placebo-controlled trial of feverfew in migraine prevention.

Authors:  J J Murphy; S Heptinstall; J R Mitchell
Journal:  Lancet       Date:  1988-07-23       Impact factor: 79.321

7.  Antibiotic radicicol binds to the N-terminal domain of Hsp90 and shares important biologic activities with geldanamycin.

Authors:  T W Schulte; S Akinaga; S Soga; W Sullivan; B Stensgard; D Toft; L M Neckers
Journal:  Cell Stress Chaperones       Date:  1998-06       Impact factor: 3.667

8.  Quantitative proteomics characterization on the antitumor effects of isodeoxyelephantopin against nasopharyngeal carcinoma.

Authors:  Guang-Rong Yan; Zilu Tan; Yang Wang; Man-Li Xu; Guangchuang Yu; Yaolan Li; Qing-Yu He
Journal:  Proteomics       Date:  2013-10-03       Impact factor: 3.984

9.  Review of Pharmacological Effects of Antrodia camphorata and Its Bioactive Compounds.

Authors:  Madamanchi Geethangili; Yew-Min Tzeng
Journal:  Evid Based Complement Alternat Med       Date:  2011-01-03       Impact factor: 2.629

Review 10.  Sesquiterpenoids lactones: benefits to plants and people.

Authors:  Martin Chadwick; Harriet Trewin; Frances Gawthrop; Carol Wagstaff
Journal:  Int J Mol Sci       Date:  2013-06-19       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.